1. Vitamin D Supplementation for Prevention of Cancer: The D2d Cancer Outcomes (D2dCA) Ancillary Study
- Author
-
Philip Raskin, Michael R. Lewis, Jean Park, James H. Ware, Ellen M Vickery, Patricia R. Sheehan, Clifford J. Rosen, Anne L. Peters, Vanita R. Aroda, Richard E. Pratley, Rowena J Dolor, Irwin G. Brodsky, Anastassios G. Pittas, Cyrus Desouza, Saul Malozowski, Jason Nelson, Adline Ghazi, Paul J. Fuss, Patrick M. O'Neil, Lawrence S. Phillips, Neda Rasouli, Karen C. Johnson, Emilia Liao, William C. Knowler, Daniel S. Hsia, Ranee Chatterjee, Sangeeta R. Kashyap, Dave Reboussin, Lisa Ceglia, Erin S. LeBlanc, Patricia Sheehan, John P. Foreyt, Rowena J. Dolor, Sun H. Kim, Chhavi Chadha, Lisa M. Neff, David C. Robbins, Myrlene A. Staten, and Bess Dawson-Hughes
- Subjects
Male ,0301 basic medicine ,Vitamin ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Population ,Overweight ,Biochemistry ,Prediabetic State ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Endocrinology ,Neoplasms ,Internal medicine ,Vitamin D and neurology ,Humans ,Medicine ,Obesity ,Prediabetes ,Vitamin D ,Risk factor ,education ,Aged ,Proportional Hazards Models ,Clinical Research Article ,education.field_of_study ,business.industry ,Biochemistry (medical) ,Hazard ratio ,Cancer ,Middle Aged ,medicine.disease ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Dietary Supplements ,Female ,medicine.symptom ,business ,Precancerous Conditions - Abstract
Context Observational studies suggest that low vitamin D status may be a risk factor for cancer. Objective In a population with prediabetes and overweight/obesity that is at higher risk of cancer than the general population, we sought to determine if vitamin D supplementation lowers the risk of cancer and precancers. Methods The Vitamin D and type 2 diabetes (D2d) cancer outcomes study (D2dCA) is an ancillary study to the D2d study, which was conducted at 22 academic medical centers in the United States. Participants had prediabetes and overweight/obesity and were free of cancer for the previous 5 years. Participants were randomized to receive vitamin D3 4000 IU daily or placebo. At scheduled study visits (4 times/year), cancer and precancer events were identified by questionnaires. Clinical data were collected and adjudicated for all reported events. Cox proportional hazard models compared the hazard ratio (HR) of incident cancers and precancers between groups. Results Over a median follow-up period of 2.9 years, among 2385 participants (mean age 60 years and 25-hydroxyvitamin D 28 ng/mL), there were 89 cases of cancer. The HR of incident cancer for vitamin D vs placebo was 1.07 (95% CI 0.70, 1.62). Of 241 participants with incident precancers, 239 had colorectal adenomatous polyps. The HR for colorectal polyps for vitamin D vs placebo was 0.83 (95% CI 0.64, 1.07). Conclusion In the D2d population of participants with prediabetes and overweight/obesity, not selected for vitamin D insufficiency, vitamin D supplementation did not have a significant effect on risk of incident cancer or colorectal polyps.
- Published
- 2021